Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1NIH 1NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 33Genitourinary 24Thoracic 19Head & Neck 12Gynecologic 11Gastrointestinal 10Sarcoma 4Other solid neoplasm 3Tumor-Agnostic 1Other hematologic neoplasm 1Lymphoid 1Endocrine 1CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Leukemia 1

Interventions

Cytarabine 83Methotrexate 59Cyclophosphamide 58Vincristine 47Daunorubicin 46Prednisone 33Mercaptopurine 33Asparaginase 33Dexamethasone 31Doxorubicin 29Gene Expression Profiling 27Etoposide 27pegaspargase 25Radiotherapy 25Filgrastim 25Thioguanine 24Leucovorin 24Flow Cytometry 23merphos 22Hydrocortisone 20Calcium Dobesilate 20Specimen Handling 18Microarray Analysis 16Idarubicin 16Granulocyte Colony-Stimulating Factor 15Peripheral Blood Stem Cell Transplantation 14Busulfan 14Polymerase Chain Reaction 13Mitoxantrone 13Gemtuzumab 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Docetaxel × Other hematologic neoplasm × Clear all
NCT00021242 2014-08-08

Docetaxel in Treating Children With Relapsed or Refractory Acute Lymphoblastic or Acute Myeloid Leukemia

Children's Oncology Group

Phase 2 Completed
12 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡